Ajanta Pharma (NSE:AJANTPHARM) EV-to-FCF: (As of Sep. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AJANTPHARM Ajanta Pharma Ltd NSE:AJANTPHARM
95 GF Score
Price ₹3,481.70
GF Value ₹3,348.50
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ajanta Pharma EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ajanta Pharma's Enterprise Value is ₹430,947 Mil. Ajanta Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0 Mil. Therefore, Ajanta Pharma's EV-to-FCF for today is .

The historical rank and industry rank for Ajanta Pharma's EV-to-FCF or its related term are showing as below:

NSE:AJANTPHARM' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 268.67
Current: 268.67

During the past 13 years, the highest EV-to-FCF of Ajanta Pharma was 268.67. The lowest was 0.00. And the median was 0.00.

NSE:AJANTPHARM's EV-to-FCF is ranked worse than
94.18% of 567 companies
in the Drug Manufacturers industry
Industry Median: 20.01 vs NSE:AJANTPHARM: 268.67

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-09-03), Ajanta Pharma's stock price is ₹3481.70. Ajanta Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ₹90.790. Therefore, Ajanta Pharma's PE Ratio (TTM) for today is 38.35.


Ajanta Pharma  (NSE:AJANTPHARM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Ajanta Pharma's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3481.70/90.790
=38.35

Ajanta Pharma's share price for today is ₹3481.70.
Ajanta Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹90.790.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Ajanta Pharma EV-to-FCF Related Terms


Ajanta Pharma EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Ajanta Pharma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ajanta Pharma EV-to-FCF Chart

Ajanta Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.69 23.49 43.87 38.30 211.08

Ajanta Pharma Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 211.08 0.00

NSE:AJANTPHARM vs ZTS: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ajanta Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ajanta Pharma EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ajanta Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Ajanta Pharma's EV-to-FCF falls into.


NSE:AJANTPHARM
95GF Score
Ajanta Pharma Ltd NSE:AJANTPHARM
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ajanta Pharma EV-to-FCF Calculation

Ajanta Pharma's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=430946.715/0
=

Ajanta Pharma's current Enterprise Value is ₹430,947 Mil.
Ajanta Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Ajanta Pharma (NSE:AJANTPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Ajanta Pharma stock appears to be overvalued. The current stock price of ₹3,481.70 is trading 4% above its estimated GF Value™ of ₹3,348.50. GuruFocus considers Ajanta Pharma to be Fairly Valued.

Key valuation signals for NSE:AJANTPHARM:

  • EV-to-FCF:
  • GF Value™: ₹3,348.50 vs. price of ₹3,481.70 (4% above fair value)
  • GF Score™: 95/100 with 6 warning signs

No single metric tells the full story. See the NSE:AJANTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ajanta Pharma Business Description

Other Exchanges 532331:India
Address M Vasanji Road, Ajanta Tower, 54-A, Chakala, Andheri East, Mumbai, MH, IND, 400 093
Ajanta Pharma Ltd is mainly involved in development, manufacturing and marketing of speciality pharmaceutical finished dosages. The operations of the Group are limited to only one segment viz. pharmaceuticals and related products. The company has presence in India, Emerging Market, Africa Institution, and USA. The company generates majority of revenue from Emerging market.
95GF Score

Get the complete analysis for NSE:AJANTPHARM

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,481.70
Price
₹3,348.50
GF Value